Use of guidelines-recommended management and outcomes among women and men with low-level: Troponin elevation insights from crusade

Sharif A. Halim, Jyotsna Mulgund, Anita Y. Chen, Matthew T. Roe, Eric D. Peterson, W. Brian Gibler, E. Magnus Ohman, L. Kristin Newby

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Background-Troponin elevation above the upper limit of normal (ULN) is diagnostic of myocardial infarction, but interpretation of "gray-zone" troponin elevations (1 to 1.5× ULN) remains uncertain. Using the CRUSADE database, we explored relationships between sex and treatment and outcomes among patients with troponin 1 to 1.5× ULN. Methods and Results-We compared treatment and outcomes among women and men using logistic generalized estimating equation method. Overall, 5049 of 85 671 (5.9%) non-ST-segment elevation acute coronary syndromes patients (2156 women, 2893 men) had troponin 1 to 1.5× ULN within 24 hours of presentation. Compared with troponin >1.5× ULN, "gray-zone" patients less often received all guidelines-indicated acute (mean composite score, 63% versus 72%) and discharge therapies (mean composite score, 73% versus 78%), but received them more frequently than patients with troponin <1× ULN (mean composite scores, 58% acute and 67% discharge). Among "gray-zone" patients, acute and discharge therapy use was similar between women and men, except acute aspirin (adjusted odds ratio, 0.80 [95% CI, 0.65 to 0.98]) and discharge angiotensin-converting enzyme inhibitors (adjusted odds ratio, 0.77 [95% CI, 0.67 to 0.88]). "Gray-zone" patients had lower mortality (2.3%) than the >1.5× ULN (4.5%) group but higher than the <1× ULN group (1.1%). Outcomes were similar among "gray-zone" women and men (adjusted odds ratios: death, 0.88 [95% CI, 0.58 to 1.35]; death/myocardial infarction, 0.77 [95% CI, 0.55 to 1.06]; transfusion, 1.04 [95% CI, 0.85 to 1.27]). Conclusions-Patients with non-ST-segment elevation acute coronary syndromes and low-level troponin elevations had lower overall risk and received less aggressive guidelines-based treatment than those with greater troponin elevations, but treatment patterns were largely similar by sex across troponin elevation groups. (Circ Cardiovasc Qual Outcomes. 2009;2:199-206.)

Original languageEnglish (US)
Pages (from-to)199-206
Number of pages8
JournalCirculation: Cardiovascular Quality and Outcomes
Volume2
Issue number3
DOIs
StatePublished - May 2009
Externally publishedYes

Keywords

  • Acute coronary syndrome
  • Outcomes
  • Troponin

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint

Dive into the research topics of 'Use of guidelines-recommended management and outcomes among women and men with low-level: Troponin elevation insights from crusade'. Together they form a unique fingerprint.

Cite this